MarketPeel
Insider Trading Intelligence
SL

Sandeep Laumas

UNCY
DIRECTOR · UNICYCIVE THERAPEUTICS, INC. · CIK 0001721664
FILING MIX · LIFETIME85%/15%
BUYS
22
SELLS
4
TOTAL VALUE
$3.08M
COMPANIES
3
ACTIVE SINCE
May 2020
HOLDINGS NOW
160,300
AVG SELL PX
$23.39
TRADE KIND
SHOWING 26 / 26
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Sandeep Laumas, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%-6.25%+1.07%-7.31%-7.31%
14d2+100.00%-23.54%+1.36%-24.91%-24.91%
30d2+100.00%-16.32%+0.12%-16.44%-16.44%
60d2+100.00%-35.55%+4.48%-40.03%-40.03%
90d2+100.00%-51.96%+4.73%-56.69%-56.69%
180d2+100.00%-61.27%+4.00%-65.27%-65.27%
1y2(2 pending)
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
UNCY · 126,300 shares · as of May 14, 2026
050,216100,432150,648200,864202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 22 buys / 4 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
UNCY
UNICYCIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,100126,300May 14, 2026May 18, 2026View →
UNCY
UNICYCIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,100126,300May 14, 2026Jun 15, 2026View →
UNCY
UNICYCIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
84,20084,200May 14, 2026May 18, 2026View →
UNCY
UNICYCIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
84,20084,200May 14, 2026Jun 15, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,00017,000Jan 9, 2026Jan 12, 2026View →
TIL
INSTIL BIO, INC.
SALE
CFO and CBO
13,00030,000Sep 10, 2025Sep 12, 2025View →
TIL
INSTIL BIO, INC.
PURCHASE
CFO and CBO
17,000$11.60$197.2K17,000Sep 10, 2025Sep 12, 2025View →
TIL
INSTIL BIO, INC.
PURCHASE
CFO and CBO
13,000$12.68$164.8K30,000Sep 10, 2025Sep 12, 2025View →
TIL
INSTIL BIO, INC.
SALE
CFO and CBO
12,461$23.88$297.6K0Sep 10, 2025Sep 12, 2025View →
TIL
INSTIL BIO, INC.
SALE
CFO and CBO
17,539$23.04$404.1K12,461Sep 10, 2025Sep 12, 2025View →
TIL
INSTIL BIO, INC.
SALE
CFO and CBO
17,00017,000Sep 10, 2025Sep 12, 2025View →
UNCY
UNICYCIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,20041,286Jul 28, 2025Jul 30, 2025View →
TIL
INSTIL BIO, INC.
PURCHASEGRANT
Stock grant
44,85144,851Apr 25, 2025Apr 28, 2025View →
TIL
INSTIL BIO, INC.
PURCHASEGRANT
Stock grant
45,00045,000Sep 18, 2024Sep 23, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,00017,000Jun 10, 2024Jun 11, 2024View →
TIL
INSTIL BIO, INC.
PURCHASEGRANT
Stock grant
80,00080,000Feb 10, 2024Feb 13, 2024View →
UNCY
UNICYCIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
189,236200,864Sep 5, 2023Sep 7, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,00017,000Jun 26, 2023Jun 28, 2023View →
TIL
INSTIL BIO, INC.
PURCHASEGRANT
Stock grant
415,000415,000Jan 8, 2023Jan 20, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,00017,000May 19, 2022May 23, 2022View →
TIL
INSTIL BIO, INC.
PURCHASEGRANT
Stock grant
234,000234,000Mar 4, 2022Jan 20, 2023View →
TIL
INSTIL BIO, INC.
PURCHASEGRANT
Stock grant
234,000$8.62$2.02M234,000Mar 4, 2022Mar 7, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,50014,500Jun 11, 2021Jun 15, 2021View →
TIL
INSTIL BIO, INC.
PURCHASEGRANT
Stock grant
200,000200,000May 11, 2021May 13, 2021View →
TIL
INSTIL BIO, INC.
PURCHASEGRANT
Stock grant
240,000240,000Mar 18, 2021Mar 22, 2021View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,00020,000May 21, 2020May 26, 2020View →
Other insiders · UNCY
Loading peer insiders…
About this filer
CIK 0001721664
ROLE
Director
PRIMARY
UNCY
COMPANIES
3
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001721664DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback